Showing results (101-110 of 477) with videos related to
Sort By:
Pageof 48
Biochemistry|October 3, 1999
Effects of inhibitors on the activity of the cytochrome b(6)f complex: evidence for the existence of two binding pockets in the lumenal siteR P Barbagallo, G Finazzi, G FortiThe Journal of Biological Chemistry|June 27, 2000
Kinetic effects of the electrochemical proton gradient on plastoquinone reduction at the Qi site of the cytochrome b6f complexR P Barbagallo, C Breyton, G FinazziLeukemia & Lymphoma|September 1, 1996
Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromesG Finazzi, U Budde, J J MichielsLeukemia|January 26, 2007
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupG Barosi, C Besses, G Birgegard, et al.Acta Haematologica|January 1, 1996
Role of anthracyclines in the treatment of adult acute lymphoblastic leukemiaR Bassan, T Lerede, A Rambaldi, et al.La Ricerca in Clinica E in Laboratorio|January 1, 1981
Spectrum of platelet aggregation abnormalities in myeloproliferative diseasesS Cortelazzo, P Viero, R Bassan, et al.Blood|January 15, 1996
All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4)A Falanga, M Marchetti, S Giovanelli, et al.Thrombosis and Haemostasis|October 29, 1982
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseasesP Viero, S Cortelazzo, R Bassan, et al.Thrombosis Et Diathesis Haemorrhagica|September 30, 1974
Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiencyT Barbui, G Cartei, T Chisesi, et al.Thrombosis and Haemostasis|June 18, 1980
Abnormal aggregation and increased size of platelets in myeloproliferative disordersS Cortelazzo, T Barbui, R Bassan, et al.Pageof 48